US 9677076
Modulation of hepatitis B virus (HBV) expression
granted A61PA61P1/16A61P29/00
Quick answer
US patent 9677076 (Modulation of hepatitis B virus (HBV) expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P1/16, A61P29/00, A61P31/14, A61P31/20